Open Journal of Gastroenterology

Volume 3, Issue 3 (July 2013)

ISSN Print: 2163-9450   ISSN Online: 2163-9469

Google-based Impact Factor: 0.23  Citations  

Helicobacter infection decreases basal colon inflammation, but increases disease activity in experimental IBD

HTML  XML Download Download as PDF (Size: 1387KB)  PP. 177-189  
DOI: 10.4236/ojgas.2013.33029    4,692 Downloads   7,083 Views  Citations

ABSTRACT

Background: Helicobacter species are best known for their roles in the pathology of gastritis; however, several Helicobacter species also colonize the intestine, and less is known about effects of Helicobacter on the development of intestinal inflammation. To evaluate contributions of Helicobacter in inflammatory bowel disease, we investigated whether and how pre-existing intestinal colonization would affect disease severity and biomarkers of inflammation in experimental IBD. Materials and Methods: Mice were infected with H. muridarum 2 weeks prior to induction of colitis mediated by 3% dextran sulfate (DSS). Disease activity index, stool blood and consistency, colon length, myeloperoxidase, histopathology, blood and lymphatic vessels, and numbers of dilated mucosal crypts were measured in control, DSS-only, H. muridarum-infected, and H. muridarum-infected + DSS mice. Results: Prior to DSS challenge, H. muridarum-infected mice showed little distal gut injury by several indices of colon inflammation with decreased blood vessel density in the submucosa, and lower lymphatic density in the mucosa and submucosa. However, after DSS colitis, H. muridarum-infected mice exhibited significantly greater disease. Weight change, stool bleeding, diarrhea, and angiogenesis were all increased in H. muridarum-infected mice in DSS colitis compared to DSS controls. Conclusions: Our data show that Helicobacter colonization of the intestine, unlike that of the stomach, lowers basal gut inflammatory scores, but increases disease activity and inflammation in an acute colitis model. Intestinal Helicobacter infection may therefore represent a significant sub-clinical factor which predisposes the gut to inflammatory injury.

Share and Cite:

Monceaux, C. , Testerman, T. , Boktor, M. , Jordan, P. , Adegboyega, P. , McGee, D. , Jennings, M. , Parker, C. , Gupta, S. , Yi, P. , Ganta, V. , Galous, H. , Manas, K. and Alexander, J. (2013) Helicobacter infection decreases basal colon inflammation, but increases disease activity in experimental IBD. Open Journal of Gastroenterology, 3, 177-189. doi: 10.4236/ojgas.2013.33029.

Cited by

[1] Role of Mucin 2 Glycoprotein and L-fucose in Interaction of Immunity and Microbiome within the Experimental Model of Inflammatory Bowel Disease
Biochemistry …, 2022
[2] Учредители: Российская академия наук
БИОХИМИЯ, 2022
[3] Helicobacter pylori infection and inflammatory bowel diseases
2021
[4] Инфекция Helicobacter pylori и воспалительные заболевания кишечника
2021
[5] Helicobacter's Effects on Colitis/Colon Cancer and the Response to Indole 3-Carbinol
2020
[6] Immune and microRNA responses to Helicobacter muridarum infection and indole-3-carbinol during colitis
2020
[7] Вклад кишечного муцина-2 в эффективность антибактериальной терапии Helicobacter spp. у лабораторных мышей
2015
[8] Parallels Between Mammals and Flies in Inflammatory Bowel Disease
Life Extension, 2015
[9] Вклад кишечного муцина‑2 в эффективность антибактериальной терапии Helicobacter spp. у лабораторных мышей
2015
[10] Helicobacter pylori infection and inflammatory bowel disease: is there a link
2014
[11] Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease
World Journal of Gastroenterology, 2014
[12] Helicobacter pylori infection and inflammatory bowel disease: Is there a link?
World J Gastroenterol, 2014
[13] ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ НАУЧНОЕ УЧРЕЖДЕНИЕ «ФЕДЕРАЛЬНЫЙ ИССЛЕДОВАТЕЛЬСКИЙ ЦЕНТР ИНСТИТУТ …

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.